CFP Antibody - #DF7320
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# DF7320, RRID:AB_2839258.
折りたたみ／展開
BFD; CFP; Complement factor P; Complement factor properdin; Factor P; PFC; PFD; PROP_HUMAN; Properdin; Properdin P factor complement;
免疫原
- P27918 PROP_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MITEGAQAPRLLLPPLLLLLTLPATGSDPVLCFTQYEESSGKCKGLLGGGVSVEDCCLNTAFAYQKRSGGLCQPCRSPRWSLWSTWAPCSVTCSEGSQLRYRRCVGWNGQCSGKVAPGTLEWQLQACEDQQCCPEMGGWSGWGPWEPCSVTCSKGTRTRRRACNHPAPKCGGHCPGQAQESEACDTQQVCPTHGAWATWGPWTPCSASCHGGPHEPKETRSRKCSAPEPSQKPPGKPCPGLAYEQRRCTGLPPCPVAGGWGPWGPVSPCPVTCGLGQTMEQRTCNHPVPQHGGPFCAGDATRTHICNTAVPCPVDGEWDSWGEWSPCIRRNMKSISCQEIPGQQSRGRTCRGRKFDGHRCAGQQQDIRHCYSIQHCPLKGSWSEWSTWGLCMPPCGPNPTRARQRLCTPLLPKYPPTVSMVEGQGEKNVTFWGRPLPRCEELQGQKLVVEEKRPCLHVPACKDPEEEEL
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - P27918 基板として
| Site | PTM Type | Enzyme | Source |
|---|---|---|---|
| S39 | Phosphorylation | Uniprot | |
| S40 | Phosphorylation | Uniprot | |
| W83 | C-Glycosylation | Uniprot | |
| W86 | C-Glycosylation | Uniprot | |
| T92 | O-Glycosylation | Uniprot | |
| W139 | C-Glycosylation | Uniprot | |
| W142 | C-Glycosylation | Uniprot | |
| W145 | C-Glycosylation | Uniprot | |
| T151 | O-Glycosylation | Uniprot | |
| W196 | C-Glycosylation | Uniprot | |
| W199 | C-Glycosylation | Uniprot | |
| S208 | O-Glycosylation | Uniprot | |
| W260 | C-Glycosylation | Uniprot | |
| W263 | C-Glycosylation | Uniprot | |
| T272 | O-Glycosylation | Uniprot | |
| W321 | C-Glycosylation | Uniprot | |
| W324 | C-Glycosylation | Uniprot | |
| W382 | C-Glycosylation | Uniprot | |
| W385 | C-Glycosylation | Uniprot | |
| W388 | C-Glycosylation | Uniprot | |
| N428 | N-Glycosylation | Uniprot |
研究背景
A positive regulator of the alternate pathway (AP) of complement. It binds to and stabilizes the C3- and C5-convertase enzyme complexes. Inhibits CFI-CFH mediated degradation of Complement C3 beta chain (C3b).
Secreted.
In plasma, properdin exists as dimers, trimers or tetramers in the relative proportions of 26:54:20. Interacts with the pro-C3-convertase enzyme complex (C3b-Bb) comprised of Complement C3 beta chain (C3b) and the Complement factor B Bb fragment (Bb), where it binds (via its TSP type-1 5 domain) with C3b and Bb. This interaction stabilizes the complex and allows it to become the active C3-convertase enzyme complex (C3b-Bb-FP). Interacts with C3b. Interacts with CFB.
TSP type-1 domain 0 binds to TSP type-1 domain 4, and TSP type-1 domain 1 binds to TSP type-1 domain 6 (PubMed:15491616, PubMed:28264884, PubMed:31507604). These interactions mediate multimerization (PubMed:15491616, PubMed:28264884, PubMed:31507604).
研究領域
· Human Diseases > Infectious diseases: Viral > Herpes simplex infection.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.